Knockdown of GPX4 or pharmacologic inhibition of this pathway re-sensitized EBV-infected NPC cells to ferroptosis, suggesting viral involvement in reinforcing Nrf2-mediated antioxidant defenses. Here, GPX4 is linked to nasopharyngeal carcinoma.